Brief: Renovorx Increases U.S. Production Of Renovocath Devices To Meet Growing Demand From Oncology Community
16/04/2025 13:43
April 16 (Reuters) - RenovoRx Inc RNXT.O: RENOVORX INCREASES U.S. PRODUCTION OF RENOVOCATH® DEVICES TO MEET GROWING DEMAND FROM ONCOLOGY COMMUNITY Source text: ID:nBw8LqrlPa Further company coverage: RNXT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies